Zydus Cadila

PLI scheme for obesity, diabetes drugs likely by 2026: Report

Jun 28, 2024, 04:13 PM IST

Indian pharma companies such as Dr. Reddy's Laboratories, Lupin, Zydus Cadila, and Sun Pharma are already working on anti-obesity drugs.

Indian pharma cos speed up anti-obesity drug development amid high demand, surge in Ozempic’s sales

Nov 21, 2023, 10:26 PM IST

Sun Pharma, Dr. Reddy's, Lupin, Torrent, and Zydus Cadila progressing obesity drug candidates in response to rising demand.

Country well prepared to meet new Covid challenge, assures civil aviation minister

Dec 23, 2022, 10:09 AM IST

Scindia was addressing a presser on the Union Health Ministry’s initiatives to tackle COVID-19.

Zydus gets USFDA approval to market generic acne drug

Jun 07, 2022, 03:49 PM IST

Zydus Lifesciences announced receiving final approval from the US health regulator to commercialize the drug with a market size of $195 million.

Why the Covid-19 Vaccination Drive for Adolescents is a Game Changer

May 06, 2022, 12:00 PM IST

The Covid-19 vaccination drive for children below the age of 18 might revive India's stuttering programme of mass inoculation of adolescents against other diseases

Zydus Cadila receives tentative US FDA nod for Pimavanserin capsules

Dec 31, 2021, 02:23 PM IST

Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

COVID-19: Covaxin likely to be the only vaccine available for 15-18 years age group

Dec 26, 2021, 10:47 PM IST

Healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given before.

Zydus Cadila gets nod for phase 2 clinical study in CAPS patients in Australia

Dec 13, 2021, 03:03 PM IST

The clinical trial in Australia will study the safety, tolerability, pharmacokinetics and pharmacodynamics in patients with CAPS, Zydus Cadila said in a statement.

Zydus Cadila receives USFDA approval to market generic cancer drug in US

Nov 20, 2021, 05:14 PM IST

The company has received final approval from the US Food and Drug Administration (USFDA) to market Decitabine for Injection in the strength of 50 mg/vial single-dose vial.

COVID-19: Zydus Cadila's vaccine to be administered only to adults as of now, say sources

Nov 14, 2021, 04:57 PM IST

The health ministry has given a go ahead to initiate the preparatory work for the inclusion of the indigenously-developed, needle-free jab in the national Covid inoculation drive.

Zydus Cadila to supply 1 crore doses of COVID-19 vaccine ZyCoV-D to Indian govt

Nov 08, 2021, 05:33 PM IST

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above. The three doses of ZyCoV-D are to be administered 28 days apart.